TY - JOUR
T1 - Comparison of the effect of sildenafil and apomorphine SL on nocturnal erections in healthy volunteers
T2 - A placebo-controlled study
AU - Salonia, Andrea
AU - Barbieri, Luigi
AU - Chen, Juza
AU - Briganti, Alberto
AU - Dehò, Federico
AU - Naspro, Richard
AU - Del Carro, Ubaldo
AU - Rokkas, Kostantinos
AU - Scattoni, Vincenzo
AU - Rigatti, Patrizio
AU - Montorsi, Francesco
PY - 2005/4
Y1 - 2005/4
N2 - Objective: To compare the effects of sildenafil and sublingual (sl) apomorphine on nocturnal erections. Methods: In a prospective, single-blinded, placebo-controlled at-home study we compared the effect of apomorphine sl and sildenafil on sleep-related erectile activity in 30 healthy potent volunteers (mean age, 26.4 years; range, 23-35 years; Erectile Function domain of the International Index of Erectile Function ≥26), not reporting any subjective sleep abnormality during 4 consecutive nights with rigidity monitoring (NPTR) with the RigiScan™ device. After the first night of adaptation, they were randomized to receive placebo or apomorphine sl 2 mg or sildenafil 50 mg taken at bedtime during the following 3 consecutive nights. Results: Sildenafil increased the mean ± SE number of erections, overall length of erectile events, and the time of erections with rigidity >60% at both tip and base, as compared to placebo. The same parameters were reduced after administration of apomorphine sl. Similar findings were observed with regards to Rigidity Activity Units and Tumescence Activity Units. Conclusions: Our results confirm that sildenafil taken at bedtime might increase nocturnal erectile activity also in young potent men as compared to placebo. Apomorphine sl taken at bedtime seems to have the opposite effect.
AB - Objective: To compare the effects of sildenafil and sublingual (sl) apomorphine on nocturnal erections. Methods: In a prospective, single-blinded, placebo-controlled at-home study we compared the effect of apomorphine sl and sildenafil on sleep-related erectile activity in 30 healthy potent volunteers (mean age, 26.4 years; range, 23-35 years; Erectile Function domain of the International Index of Erectile Function ≥26), not reporting any subjective sleep abnormality during 4 consecutive nights with rigidity monitoring (NPTR) with the RigiScan™ device. After the first night of adaptation, they were randomized to receive placebo or apomorphine sl 2 mg or sildenafil 50 mg taken at bedtime during the following 3 consecutive nights. Results: Sildenafil increased the mean ± SE number of erections, overall length of erectile events, and the time of erections with rigidity >60% at both tip and base, as compared to placebo. The same parameters were reduced after administration of apomorphine sl. Similar findings were observed with regards to Rigidity Activity Units and Tumescence Activity Units. Conclusions: Our results confirm that sildenafil taken at bedtime might increase nocturnal erectile activity also in young potent men as compared to placebo. Apomorphine sl taken at bedtime seems to have the opposite effect.
KW - Apomorphine
KW - Nocturnal erections
KW - RigiScan
KW - Sildenafil
UR - http://www.scopus.com/inward/record.url?scp=20144375583&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2004.12.008
DO - 10.1016/j.eururo.2004.12.008
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 15774253
AN - SCOPUS:20144375583
SN - 0302-2838
VL - 47
SP - 524
EP - 529
JO - European Urology
JF - European Urology
IS - 4
ER -